<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37519183</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>23</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0219-6352</ISSN><JournalIssue CitedMedium="Internet"><Volume>22</Volume><Issue>4</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal of integrative neuroscience</Title><ISOAbbreviation>J Integr Neurosci</ISOAbbreviation></Journal><ArticleTitle>Lack of Association between <i>CD33 rs3865444</i> and Amyotrophic Lateral Sclerosis: A Case-Control Study.</ArticleTitle><Pagination><StartPage>106</StartPage><MedlinePgn>106</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.31083/j.jin2204106</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Microglial activation is considered to assume a role in the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). To date, the relationship between ALS and the <i>rs3865444</i> polymorphism of the cluster of differentiation 33 (CD33) has not been explored. The current report aimed to investigate the potential connection between <i>CD33 rs3865444</i> and ALS.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Patients diagnosed with sporadic ALS according to the revised El Escorial criteria, as well as age and sex matched community controls, were enrolled. Two evenly numbered, age and sex matched groups of 155 participants each were genotyped.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">No association was found between <i>rs3865444</i> and ALS [log-additive odds ratio (OR) = 0.83 (0.57, 1.22), over-dominant OR = 0.86 (0.55, 1.36), recessive OR = 0.73 (0.25, 2.17), dominant OR = 0.82 (0.52, 1.29), co-dominant OR1 = 0.68 (0.23, 2.05) and co-dominant OR2 = 0.84 (0.53, 1.33)]. Moreover, no relationship was established between rs3865444 and the age of ALS onset based on both unadjusted and sex adjusted Cox-proportional hazards models. Finally, no association between rs3865444 and ALS was found in subgroup analyses based on the site of ALS onset (bulbar or spinal) and sex.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The current analysis is the first to report that rs3865444 is not linked to ALS. Larger multi-racial studies are required to confirm these findings.</AbstractText><CopyrightInformation>&#xa9; 2023 The Author(s). Published by IMR Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Siokas</LastName><ForeName>Vasileios</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liampas</LastName><ForeName>Ioannis</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aloizou</LastName><ForeName>Athina-Maria</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bakirtzis</LastName><ForeName>Christos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>B' Department of Neurology, AHEPA University Hospital, Aristotle University of Thessaloniki, 54636 Thessaloniki, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tsouris</LastName><ForeName>Zisis</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nousia</LastName><ForeName>Anastasia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Speech and Language Therapy, University of Ioannina, 45110 Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nasios</LastName><ForeName>Grigorios</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Speech and Language Therapy, University of Ioannina, 45110 Ioannina, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papadimitriou</LastName><ForeName>Dimitra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Neurological Department, Henry Dunant Hospital Center, 11526 Athens, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavdas</LastName><ForeName>Eleftherios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences, University of West Attica, 12243 Athens, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Imaging, Animus Kyanoys Larisas Hospital, 41222 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liakos</LastName><ForeName>Panagiotis</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Laboratory of Biochemistry, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bogdanos</LastName><ForeName>Dimitrios P</ForeName><Initials>DP</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hadjigeorgiou</LastName><ForeName>Georgios M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Medical School, University of Cyprus, 1678 Nicosia, Cyprus.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dardiotis</LastName><ForeName>Efthimios</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurogenetics, University Hospital of Larissa, Faculty of Medicine, University of Thessaly, 41100 Larissa, Greece.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>5287</GrantID><Agency>Research Committee of the University of Thessaly</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>J Integr Neurosci</MedlineTA><NlmUniqueID>101156357</NlmUniqueID><ISSNLinking>0219-6352</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C571163">CD33 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D063268">Sialic Acid Binding Ig-like Lectin 3</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D063268" MajorTopicYN="N">Sialic Acid Binding Ig-like Lectin 3</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CD33</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">cluster of differentiation 33</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">rs3865444</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest. Vasileios Siokas, Christos Bakirtzis, Efthimios Dardiotis, and Ioannis Liampas are serving as one of the Guest editors of this journal. We declare that Vasileios Siokas, Christos Bakirtzis, Efthimios Dardiotis, and Ioannis Liampas had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Gernot Riedel.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>3</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37519183</ArticleId><ArticleId IdType="doi">10.31083/j.jin2204106</ArticleId><ArticleId IdType="pii">S0219-6352(23)00573-9</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>